SIX WEEKS VS SIX MONTHS OF VALGANCICLOVIR IN INFANTS WITH SYMPTOMATIC CONGENITA

有症状先天性婴儿服用缬更昔洛韦六周与六个月的比较

• 批准号: 7951753
• 负责人: Jin-Young Han
• 金额: $ 0.07万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951753
• 关键词: Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Cytomegalovirus; Disease; Funding; Grant; Hearing; Infant; Institution; Oral; Outcome; Research; Research Personnel; Resources; Solutions; Source; United States National Institutes of Health; Valganciclovir

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this study is to compare the impact on hearing outcomes of six weeks versus six months of valganciclovir oral solution in infants with symptomatic congentical cytomegalovirus (CMV) disease.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的主要目的是比较症状性先天性巨细胞病毒（CMV）疾病婴儿服用缬更昔洛韦口服液6周与6个月对听力结果的影响。